4//SEC Filing
Groeppel Manfred 4
Accession 0001193805-20-000880
CIK 0001280776other
Filed
Jul 21, 8:00 PM ET
Accepted
Jul 22, 4:06 PM ET
Size
7.1 KB
Accession
0001193805-20-000880
Insider Transaction Report
Form 4
IMMUNIC, INC.IMUX
Groeppel Manfred
Chief Operating Officer
Transactions
- Sale
Common Stock
2020-07-21$15.62/sh−650$10,155→ 278,830 total(indirect: See footnote) - Sale
Common Stock
2020-07-20$14.44/sh−5,000$72,201→ 279,480 total(indirect: See footnote)
Footnotes (2)
- [F1]These shares were sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Plan"). The Plan was adopted in connection with certain tax liabilities related to the issuance of shares in the April 2019 exchange transaction between the Issuer (then known as Vital Therapies, Inc.) and Immunic AG.
- [F2]The Reporting Person is Director of Groeppel Investments UG (haftungsbeschrankt), which is the record holder of 278,830 shares of common stock of the Issuer, and exercises voting and dispositive power over such shares.
Documents
Issuer
IMMUNIC, INC.
CIK 0001280776
Entity typeother
Related Parties
1- filerCIK 0001773674
Filing Metadata
- Form type
- 4
- Filed
- Jul 21, 8:00 PM ET
- Accepted
- Jul 22, 4:06 PM ET
- Size
- 7.1 KB